Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 8 years
- Director since
- 2023
8 years of board service in total across 2 boards, counting each seat separately. Longest: Royalty Pharma plc, 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Royalty Pharma plc June 4, 202699.7%
-
Regeneron Pharmaceuticals Inc. June 13, 202582.5%
-
Royalty Pharma plc May 12, 202598.9%
-
Royalty Pharma plc June 6, 202498.9%
-
Royalty Pharma plc June 22, 202399.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 30, 2026 | Royalty Pharma plc | Grant or award | +642 | $58.41 | $37,499 |
| Jun 30, 2026 | Royalty Pharma plc | Grant or award | +689 | $54.40 | $37,482 |
| Jun 5, 2026 | Royalty Pharma plc | Grant or award | +4,545 | — | — |
| Mar 31, 2026 | Royalty Pharma plc | Grant or award | +815 | $45.98 | $37,474 |
| Jan 7, 2026 | Regeneron Pharmaceuticals Inc. | Option exercise | +1,500 | $374.12 | $561,180 |
| Jan 7, 2026 | Regeneron Pharmaceuticals Inc. | Open-market sale | −1,500 | $800.00 | $1,200,000 |
| Jan 2, 2026 | Regeneron Pharmaceuticals Inc. | Grant or award | +155 | — | — |
| Dec 31, 2025 | Royalty Pharma plc | Grant or award | +967 | $38.74 | $37,462 |
| Nov 20, 2025 | Regeneron Pharmaceuticals Inc. | Option exercise | +760 | $371.40 | $282,264 |
| Nov 20, 2025 | Regeneron Pharmaceuticals Inc. | Open-market sale | −760 | $750.00 | $570,000 |
| Sep 30, 2025 | Royalty Pharma plc | Grant or award | +1,047 | $35.79 | $37,472 |
| Jun 30, 2025 | Royalty Pharma plc | Grant or award | +1,064 | $35.24 | $37,495 |
| May 13, 2025 | Royalty Pharma plc | Grant or award | +7,614 | — | — |
| Mar 31, 2025 | Royalty Pharma plc | Grant or award | +1,141 | $32.87 | $37,505 |
| Jan 2, 2025 | Regeneron Pharmaceuticals Inc. | Grant or award | +166 | — | — |
Questions about Bonnie L. Bassler
What boards is Bonnie L. Bassler on?
Bonnie L. Bassler sits on the boards of Regeneron Pharmaceuticals Inc. and Royalty Pharma plc.
How long has Bonnie L. Bassler served on boards?
Our records show at least 8 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.